Cleared Traditional

K850686 - ANTISERUM TO HUMAN PREALBUMIN
(FDA 510(k) Clearance)

K850686 · Kent Laboratories, Inc. · Immunology
Nov 1985
Decision
253d
Days
Class 1
Risk

K850686 is an FDA 510(k) clearance for the ANTISERUM TO HUMAN PREALBUMIN, a Prealbumin, Antigen, Antiserum, Control (Class I — General Controls, product code JZJ), submitted by Kent Laboratories, Inc. (Redmond, US). The FDA issued a Cleared decision on November 1, 1985, 253 days after receiving the submission on February 21, 1985. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5060.

Submission Details

510(k) Number K850686 FDA.gov
FDA Decision Cleared SESE
Date Received February 21, 1985
Decision Date November 01, 1985
Days to Decision 253 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary

Device Classification

Product Code JZJ — Prealbumin, Antigen, Antiserum, Control
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.5060

Similar Devices — JZJ Prealbumin, Antigen, Antiserum, Control

All 10
RANDOX PREALBUMIN
K000661 · Randox Laboratories, Ltd. · Apr 2000
TINA-QUANT PREALBUMIN
K972638 · Boehringer Mannheim Corp. · Jan 1998
HUMAN PREALBUMIN RADIAL IMMUNODIFFUSION KIT
K951966 · Kent Laboratories, Inc. · Jun 1995
PREALBUMIN IMMUNOLOGICAL NL TEST KIT
K913672 · The Binding Site, Ltd. · Dec 1991
SPQ(TM) TEST SYSTEM FOR PREALBUMIN
K884297 · Atlantic Antibodies · Nov 1988
SPQ(TM) TEST SYSTEM FOR MICROALBUMIN
K884298 · Atlantic Antibodies · Nov 1988